Low Dose Vs Conventional Rituximab Regimen in Pemphigus Vulgaris – A Retrospective Single Centre Comparative Analysis to Assess the Clinical Efficacy and Cost-Effectiveness
Background: Rituximab (RTX) is considered the first-line treatment for pemphigus vulgaris (PV), a B-cell-mediated autoimmune bullous disease. However, no clear consensus on the optimum dosage has been achieved yet. Objectives: To compare the clinical efficiency and cost-effectiveness of a low-dose (...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-07-01
|
| Series: | Indian Dermatology Online Journal |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/idoj.idoj_534_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|